Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause

OBJECTIVE: Two phase 3, randomized, placebo-controlled trials demonstrated that low-dose paroxetine 7.5 mg reduced the frequency and severity of vasomotor symptoms (VMS) associated with menopause and had a favorable tolerability profile. The impact of paroxetine 7.5 mg on body weight and sexual func...

Descripción completa

Detalles Bibliográficos
Autores principales: Portman, David J., Kaunitz, Andrew M., Kazempour, Kazem, Mekonnen, Hana, Bhaskar, Sailaja, Lippman, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott-Raven Publishers 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175016/
https://www.ncbi.nlm.nih.gov/pubmed/24552977
http://dx.doi.org/10.1097/GME.0000000000000210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175016/
https://www.ncbi.nlm.nih.gov/pubmed/24552977
http://dx.doi.org/10.1097/GME.0000000000000210

Ejemplares similares